Zobrazeno 1 - 5
of 5
pro vyhledávání: '"E K Zilber"'
Publikováno v:
Инфекция и иммунитет, Vol 10, Iss 4, Pp 782-788 (2020)
Current century has been highlighted with rise in allergic pathology, and environment markedly affects it via epigenetic mechanisms. Allergy research in Russia and Finland has been conducted for many years, of larger scale recorded in the latter, sti
Externí odkaz:
https://doaj.org/article/b162dd1f6c5644398962ba4a7d5196b7
Autor:
P K Yablonskiy, T I Vinogradova, Yu N Levashev, M V Pavlova, E K Zilber, A A Starshinova, N V Sapozhnikova, I V Chernokhaeva, L I Archakova, N V Zabolotnykh, M L Vitovskaya
Publikováno v:
Терапевтический архив, Vol 88, Iss 3, Pp 111-115 (2016)
The paper sets forth the stages of design and introduction of the new Russian tuberculosis (TB) drug perchlozon registered in the Russian Federation in 2012. Based on the results of Phases I-III clinical trials, the authors evaluate the efficacy and
Externí odkaz:
https://doaj.org/article/fb038c632bd145359e573e43d0d89e97
Autor:
M. V. Pavlova, N. V. Sapozhnikova, L. I. Archakova, P. V. Gavrilov, A. A. Starshinova, E. K. Zilber
Publikováno v:
Туберкулез и болезни лёгких, Vol 0, Iss 3, Pp 67-71 (2014)
Therapy in pregnant women with tuberculosis always presents certain difficulties and sets regarding not only the status of the mother, but also that of her baby. Tuberculosis and pregnancy have been mostly recently considered to be incompatible. The
Externí odkaz:
https://doaj.org/article/e55c7a5d26da469888bda328be71c2c8
Autor:
M. V. Pavlova, E. K. Zilber, I. B. Savin, L. I. Archakova, P. V. Gavrilov, P. K. Yablonsky, O. A. Tamm, O. S. Volodich, L. D. Kiryukhina
Publikováno v:
Russian Pulmonology. :65-68
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a75814a32ab9aef10e980cce05c1f19b
https://doi.org/10.18093/0869-0189-2013-0-6-65-68
https://doi.org/10.18093/0869-0189-2013-0-6-65-68
Autor:
T. I. Vinogradova, N. V. Sapozhnikova, Yu. N. Levashev, Piotr Yablonskiy, I. V. Chernokhaeva, M. L. Vitovskaya, N. V. Zabolotnykh, Pavlova Mv, A. A. Starshinova, E. K. Zilber, Ludmila Archakova
Publikováno v:
Терапевтический архив, Vol 88, Iss 3, Pp 111-115 (2016)
ResearcherID
ResearcherID
The paper sets forth the stages of design and introduction of the new Russian tuberculosis (TB) drug perchlozon registered in the Russian Federation in 2012. Based on the results of Phases I-III clinical trials, the authors evaluate the efficacy and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df454b8bf06694dd21f4435b16c4b522
https://doi.org/10.17116/terarkh2016883111-115
https://doi.org/10.17116/terarkh2016883111-115